Akari Therapeutics Plc Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Akari Therapeutics Plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2014 to Q1 2024.
  • Akari Therapeutics Plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$4.04M, a 17.1% increase year-over-year.
  • Akari Therapeutics Plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$4.76M, a 36.4% increase from 2022.
  • Akari Therapeutics Plc annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$7.49M, a 60.3% increase from 2021.
  • Akari Therapeutics Plc annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$18.8M, a 11.2% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$4.04M +$836K +17.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 -$4.88M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2020 -$7.74M -$7.97M -3481% Jan 1, 2020 Mar 31, 2020 20-F 2021-04-21
Q1 2019 $229K Jan 1, 2019 Mar 31, 2019 20-F 2021-04-21
Q1 2016 -$7.44M -$5.45M -274% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-12
Q1 2015 -$1.99M +$59.5K +2.91% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q1 2014 -$2.05M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.